Frank Wu

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

Keith T. Flaherty, Caroline Robert, Peter Hersey et al. · New England Journal of Medicine · 2012 · 2.1K citations · Full text

Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group

Keith T. Flaherty, Caroline Robert, Peter Hersey et al. · Zurich Open Repository and Archive (University of Zurich) · 2012 · 1.3K citations

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)

George R. Blumenschein, Egbert F. Smit, David Planchard et al. · Annals of Oncology · 2015 · 355 citations · Full text

Non-small-cell Lung Cancer, Medicine, Pharmacology +10

Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies

Xiaozhong Qian, William J. LaRochelle, Gulshan Ara et al. · Molecular Cancer Therapeutics · 2006 · 134 citations

The impact of endometrioma and laparoscopic cystectomy on serum anti-Müllerian hormone levels

Yuh‐Ming Hwu, Frank Wu, Sheng‐Hsiang Li et al. · Reproductive Biology and Endocrinology · 2011 · 126 citations · Full text